Cargando…
Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is the main subtype of non-small cell lung cancer with a low survival prognosis. We aimed to generate a prognostic model for the postoperative recurrence of LUAD. METHODS: The methylated DNA data of LUAD patients were downloaded from the Cancer Genome Atlas (TC...
Autores principales: | Luo, Wei-Ming, Wang, Zheng-Yu, Zhang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909272/ https://www.ncbi.nlm.nih.gov/pubmed/29713243 http://dx.doi.org/10.1186/s12935-018-0547-6 |
Ejemplares similares
-
An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020) -
A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020) -
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021) -
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021) -
Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022)